New drug ORKA-002 tested in humans for first time
NCT ID NCT06944379
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 36 times
Summary
This early-stage study tests the safety of a new drug called ORKA-002 in 24 healthy adults aged 18 to 65. Participants receive a single dose and are monitored for side effects and how the drug moves through the body. The goal is to gather initial safety data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Oruka Therapeutics Investigative Site
Christchurch, New Zealand, New Zealand
Conditions
Explore the condition pages connected to this study.